AI assistant
Sending…
FIBROGEN INC — Director's Dealing 2015
Dec 19, 2015
34576_dirs_2015-12-18_c8767743-917a-43e3-86eb-258c71ad3fbf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2015-12-17
Reporting Person: VALONE FRANK H MD (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-17 | Common Stock | G | 2500 | $0.00 | Disposed | 86840 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4000 | Indirect |
More from FIBROGEN INC
Regulatory Filings
2026
Apr 9
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Nov 17
Major Shareholding Notification
2025
Nov 15
Interim / Quarterly Report
2025
Nov 10
Regulatory Filings
2025
Nov 10